Table 1 from Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma
Authors:
- Reinhard DummerReinhard Dummer
- Shahneen SandhuShahneen Sandhu
- Wilson H. MillerWMWilson H. Miller
- Marcus O. ButlerMBMarcus O. Butler
- Matthew H. TaylorMTMatthew H. Taylor
- Lucie HeinzerlingLHLucie Heinzerling
- Christian U. BlankCBChristian U. Blank
- Eva Muñoz-CouseloEMEva Muñoz-Couselo
- Howard A. BurrisHBHoward A. Burris
- Michael A. PostowMPMichael A. Postow
- Bartosz ChmielowskiBCBartosz Chmielowski
- Mark R. MiddletonMMMark R. Middleton
Open Access
- 3 June 2025
- other
- Published by American Association for Cancer Research (AACR)